Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Venclyxto 50 mg film-coated tablets EU/1/16/1138/003-004 |
Venetoclax | AbbVie Deutschland GmbH & Co. KG | — |
| VISTABEL, 4 Allergan Units/0.1ml, Powder for solution for injection PA1824/020/001 |
Botulinum Toxin Type A | AbbVie Limited | Marketed |
| Xydalba EU/1/14/986/001 |
Dalbavancin hcl | AbbVie Deutschland GmbH & Co. KG | — |
| Zemplar 1 microgram capsules, soft PA1824/005/001 |
Paricalcitol | AbbVie Limited | Marketed |
| Zemplar 2 micrograms capsules, soft PA1824/005/002 |
Paricalcitol | AbbVie Limited | Marketed |
| Zemplar 5 micrograms/ml solution for injection PA1824/005/004 |
Paricalcitol | AbbVie Limited | Marketed |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.